Order Article Reprints

Lussana F, Caprioli C, Stefanoni P, Pavoni C, Spinelli O, Buklijas K, Michelato A, Borleri G, Algarotti A, Micò C, et al. Molecular Detection of Minimal Residual Disease before Allogeneic Stem Cell Transplantation Predicts a High Incidence of Early Relapse in Adult Patients with NPM1 Positive Acute Myeloid Leukemia. Cancers. 2019; 11(10):1455. https://doi.org/10.3390/cancers11101455

Lussana, Federico, Chiara Caprioli, Paola Stefanoni, Chiara Pavoni, Orietta Spinelli, Ksenija Buklijas, Anna Michelato, GianMaria Borleri, Alessandra Algarotti, Caterina Micò, and et al. 2019. "Molecular Detection of Minimal Residual Disease before Allogeneic Stem Cell Transplantation Predicts a High Incidence of Early Relapse in Adult Patients with NPM1 Positive Acute Myeloid Leukemia" Cancers 11, no. 10: 1455. https://doi.org/10.3390/cancers11101455

Lussana, F., Caprioli, C., Stefanoni, P., Pavoni, C., Spinelli, O., Buklijas, K., Michelato, A., Borleri, G., Algarotti, A., Micò, C., Grassi, A., Intermesoli, T., & Rambaldi, A. (2019). Molecular Detection of Minimal Residual Disease before Allogeneic Stem Cell Transplantation Predicts a High Incidence of Early Relapse in Adult Patients with NPM1 Positive Acute Myeloid Leukemia. Cancers, 11(10), 1455. https://doi.org/10.3390/cancers11101455